Supplementary Figure 2. SMAD3 mediates resistance to oxaliplatin by regulating DNA damage/repair.
No takes yet. Share an insight, caveat, or question.
Ballout et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: